SCHEMBL17126979

SCHEMBL17126979

CCOCCSC(C(=O)c1ccccc1)C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRSS1 P07477 6/20 0.40
▸ CTSG P08311 6/20 0.40
▸ CTRB1 P17538 6/20 0.40
▸ CMA1 P23946 6/20 0.40
▸ ALKBH5 Q6P6C2 1/20 0.38
▸ PGR P06401 1/20 0.38
▸ ADRA2A P08913 1/20 0.38
▸ ADRA2B P18089 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ TAAR1 Q96RJ0 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CES2 O00748 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17126976 0.90 PPARA (0.40) ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL15935680 0.85 SMN1; SMN2 (0.46) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL17777239 0.83 SLC2A1 (0.48) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL17127022 0.83 PTGS2 (0.38) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL17127019 0.82 LMNA (0.41) ALDH1A1KMT2ALMNASMN1; SMN2NPC1
SCHEMBL17126973 0.82 SMN1; SMN2 (0.43) ALDH1A1MEN1KMT2ALMNASMN1; SMN2
SCHEMBL17127337 0.82 KMT2A (0.35) ALDH1A1MEN1KMT2ASMN1; SMN2NPC1
SCHEMBL15172842 0.81 PRSS1 (0.45) PRSS1CTSGCTRB1CMA1ALKBH5
SCHEMBL17127030 0.79 MCHR1 (0.39) ALDH1A1LMNANPC1RAB9A
SCHEMBL17126862 0.78 AKR1C3 (0.39) ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS PRSS1 2302/4885CTSG 1252/4885CTRB1 1976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback